Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Luye Pharma Group Limited Earnings Release 2006

Jul 27, 2006

50431_rns_2006-07-27_a4c9256a-9772-4757-b09d-6e75305e95d9.htm

Earnings Release

Open in viewer

Opens in your device viewer

Listed Company Information

Listed Company Information
TAKSON HOLDINGS<00918> - Results Announcement

Takson Holdings Limited announced on 27/07/2006:
(stock code: 00918 )
Year end date: 31/03/2006
Currency: HKD
Auditors' Report: Unqualified

(Audited )
(Audited ) Last
Current Corresponding
Period Period
from 01/04/2005 from 01/04/2004
to 31/03/2006 to 31/03/2005
Note ('000 ) ('000 )
Turnover : 135,278 110,608
Profit/(Loss) from Operations : (19,676) 15,465
Finance cost : (4,487) (2,707)
Share of Profit/(Loss) of
Associates : N/A N/A
Share of Profit/(Loss) of
Jointly Controlled Entities : N/A N/A
Profit/(Loss) after Tax & MI : (20,454) 11,424
% Change over Last Period : N/A %
EPS/(LPS)-Basic (in dollars) : (0.0446) 0.0293
-Diluted (in dollars) : N/A N/A
Extraordinary (ETD) Gain/(Loss) : N/A N/A
Profit/(Loss) after ETD Items : (20,454) 11,424
Final Dividend : N/A N/A
per Share
(Specify if with other : N/A N/A
options)

B/C Dates for
Final Dividend : N/A
Payable Date : N/A
B/C Dates for Annual
General Meeting : 23/08/2006 to 25/08/2006 bdi.
Other Distribution for : N/A
Current Period

B/C Dates for Other
Distribution : N/A

Remarks:

(Loss) / earning per share

The calculation of basic (loss) / earning per share is based on the Group's Loss
attributable to equity holders of HK$20,454,000. (2005 restated: HK$11,424,000)

(Loss) / basic earning per share is calculated by the weighted average number of
459,086,000 ordinary shares (2005:389,500,000) in issue during the year. No diluted
earnings per share is presented as there is no dilutive potential ordinary share for the
years ended 31st March 2006 and 2005.